✦ LIBER ✦

Quality control in multicentric clinical trials. An experience of the EORTC Gynecological Cancer Cooperative Group

✍ Scribed by G Favalli; J.B Vermorken; K Vantongelen; J Renard; A.T Van Oosterom; S Pecorelli

Book ID: 117656828
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 220 KB
Volume: 36
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(00)00090-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of medroxyprogesterone ac

Phase II trial of medroxyprogesterone acetate in advanced ovarian cancer: An EORTC gynecological cancer cooperative group study

✍ J.V.Th.H. Hamerlynck; A.P. Maskens; C. Mangioni; M.E.L. van der Burg; J.A.M.J. W 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Evaluating Health-Related Quality of Lif

Evaluating Health-Related Quality of Life in Cancer Clinical Trials: The National Cancer Institute of Canada Clinical Trials Group Experience

✍ David Osoba; Andrea Bezjak; Michael Brundage; Joseph Pater 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN18: QUALITY OF LIFE IN CANCER CLINICA

PCN18: QUALITY OF LIFE IN CANCER CLINICAL TRIALS — AN OVERVIEW OF APPROACHES WITHIN THE EORTC

✍ A Bottomley 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Phase II study of vindesine in dissemina

Phase II study of vindesine in disseminated squamous cell carcinoma of the uterine cervix: an EORTC Gynecological cancer Cooperative Group study

✍ J. B. VERMORKEN; F. LANDONI; S. PECORELLI; M. J. PICCART; M. E. L. VAN DER BURG; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 435 KB

Experience with the use of generalized d

Experience with the use of generalized data base management systems in cooperative group clinical trials (a project of the gynecologic oncology group)

✍ John A. Blessing; Brian N. Bundy; Peter A. Reese; Roger L. Priore 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 422 KB

Practical issues in quality of life asse

Practical issues in quality of life assessment in multicentre trials conducted by the Swiss Group for Clinical Cancer Research

✍ Jürg Bernhard; Heidi Gusset; Christoph Hürny 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

Quality of life (QOL) assessment has become an integrated part in some advanced disease trials and to a lesser extent in early disease trials conducted by the Swiss Group for Clinical Cancer Research (SAKK). In general, the concept of QOL endpoints and the additional work of collecting these data is